Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Latanoprost Patent Expiration

Latanoprost is Used for managing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It was first introduced by Upjohn Us 2 Llc in its drug Xalatan on Jun 5, 1996. Other drugs containing Latanoprost are Iyuzeh, Xelpros. 12 different companies have introduced drugs containing Latanoprost.


Latanoprost Patents

Given below is the list of patents protecting Latanoprost, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Iyuzeh US8637054 Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives Jul 08, 2031 Thea Pharma
Xelpros US9539262 Ophthalmic composition comprising a prostaglandin Oct 15, 2028 Sun Pharm
Xelpros US9629852 Ophthalmic composition comprising a prostaglandin Sep 12, 2029 Sun Pharm


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Latanoprost's patents.

Given below is the list recent legal activities going on the following patents of Latanoprost.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 10 Jul, 2024 US9539262
Payment of Maintenance Fee, 4th Year, Large Entity 26 Oct, 2020 US9629852
Payment of Maintenance Fee, 4th Year, Large Entity 10 Jul, 2020 US9539262
Recordation of Patent Grant Mailed 25 Apr, 2017 US9629852
Patent Issue Date Used in PTA Calculation 25 Apr, 2017 US9629852
Email Notification 06 Apr, 2017 US9629852
Issue Notification Mailed 05 Apr, 2017 US9629852
Dispatch to FDC 17 Mar, 2017 US9629852
Application Is Considered Ready for Issue 16 Mar, 2017 US9629852
Issue Fee Payment Verified 13 Mar, 2017 US9629852



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Latanoprost Generics

Several generic applications have been filed for Latanoprost. The first generic version for Latanoprost was by Apotex Inc and was approved on Mar 22, 2011. And the latest generic version is by Eugia Pharma Specialities Ltd and was approved on Sep 3, 2019.

Given below is the list of companies who have filed for Latanoprost generic.


1. SOMERSET

Somerset Therapeutics Llc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Somerset.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005% solution/drops Prescription OPHTHALMIC AT Mar 22, 2011


2. SANDOZ

Sandoz Inc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005% solution/drops Prescription OPHTHALMIC AT Mar 22, 2011


3. APOTEX INC

Apotex Inc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Apotex Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005% solution/drops Discontinued OPHTHALMIC N/A Mar 22, 2011


4. CARNEGIE

Carnegie Pharmaceuticals Llc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Carnegie.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005% solution/drops Prescription OPHTHALMIC AT Feb 11, 2013


5. FDC LTD

Fdc Ltd has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Fdc Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005% solution/drops Prescription OPHTHALMIC AT Apr 22, 2016


6. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005% solution/drops Discontinued OPHTHALMIC N/A Sep 3, 2019


7. EPIC PHARMA LLC

Epic Pharma Llc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005% solution/drops Discontinued OPHTHALMIC N/A Jul 19, 2011


8. BAUSCH AND LOMB

Bausch And Lomb Inc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Bausch And Lomb.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005% solution/drops Prescription OPHTHALMIC AT Mar 22, 2011


9. AMRING PHARMS

Amring Pharmaceuticals Inc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Amring Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005% solution/drops Prescription OPHTHALMIC AT Mar 22, 2011